Inbrain Neuroelectronics, a Barcelona, Spain-based clinical-stage neurotechnology company, received a €4M grant by the Spanish Ministry of Industry and Tourism through the PERTE Chip initiative.
The company intends to allocate the amount to accelerate the development of its brain-computer interface technology that integrates intelligent computing and graphene-based materials to decode and modulate real time brain activity for therapeutic purposes.
Led by CEO Carolina Aguilar, Inbrain Neuroelectronics is a real-time precision neurology company with a graphene-based brain-computer interface therapeutics (BCI-Tx) platform. Its technology combines neural decoding and micrometric modulation to deliver personalized, adaptive treatments for conditions like Parkinson’s, epilepsy, and stroke rehabilitation. By continuously monitoring and adjusting therapies in real-time, its AI-driven platform enhances outcomes while reducing side effects.
FinSMEs
09/05/2025